Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 27, 2025 10:18 ET | Source: Foundation for Opioid Response Efforts

FORE Awards $2.1 Million in New Funding to Support Workforce Development and Innovative Approaches to Treatment and Prevention of Substance Use Disorder

New York, March 27, 2025 (GLOBE NEWSWIRE) -- The Foundation for Opioid Response Efforts (FORE) today announced grant awards totaling $2.1 million to four organizations dedicated to strengthening the...
November 25, 2024 10:31 ET | Source: Partnership for a Drug-Free New Jersey

Piscataway Senior Joins PDFNJ to Knock Out Opioid Abuse

PISCATAWAY, NJ, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Piscataway High School Senior Tanvi Narava is on a mission to fight the opioid epidemic in her community and New Jersey’s Knock Out Opioid Abuse Day...
April 02, 2024 08:30 ET | Source: BioCorRx Inc

BioCorRx Reports Business Update for 2023

ANAHEIM, CA, April 02, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire — BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance abuse and...
July 11, 2023 14:54 ET | Source: Spark Biomedical

Spark Biomedical’s second-generation device, Sparrow® Ascent, Receives FDA Clearance for Opioid Withdrawal Relief in Adults

DALLAS, TX, July 11, 2023 (GLOBE NEWSWIRE) -- Spark Biomedical, Inc., a leading innovator in wearable neurostimulation development, is proud to announce that its next-generation, groundbreaking...
July 11, 2023 14:38 ET | Source: Spark Biomedical

Spark Biomedical’s second-generation device, Sparrow® Ascent, Receives FDA Clearance for Opioid Withdrawal Relief in Adults

DALLAS, TX, July 11, 2023 (GLOBE NEWSWIRE) -- Spark Biomedical, Inc., a leading innovator in wearable neurostimulation development, is proud to announce that its next-generation, groundbreaking...
July 11, 2023 14:31 ET | Source: Spark Biomedical

Spark Biomedical’s second-generation device, Sparrow® Ascent, Receives FDA Clearance for Opioid Withdrawal Relief in Adults

DALLAS, TX, July 11, 2023 (GLOBE NEWSWIRE) -- Spark Biomedical, Inc., a leading innovator in wearable neurostimulation development, is proud to announce that its next-generation, groundbreaking...
February 13, 2023 08:00 ET | Source: Vituity

Jovive Health Launches New Medication-Assisted Treatment Services

EMERYVILLE, Calif., Feb. 13, 2023 (GLOBE NEWSWIRE) -- Jovive Health, a provider of flexible, patient-centric primary and urgent care services that is owned and operated by Vituity, is now providing...
April 13, 2022 08:00 ET | Source: American College of Medical Toxicology

X Waiver Mini-Course Expands Emergency Clinician Recognition and Treatment of Opioid Withdrawal, Study Finds

Phoenix, AZ, April 13, 2022 (GLOBE NEWSWIRE) -- “A Brief Educational Intervention to Increase ED Initiation of Buprenorphine for Opioid Use Disorder (OUD)” was a study funded by a grant to the...
November 04, 2021 10:25 ET | Source: Spark Biomedical

Spark Biomedical, Inc enlists the expertise of former Deputy Secretary of the U.S. Department of Health and Human Services, Eric D. Hargan, to help make novel opioid withdrawal treatment more accessible and affordable for patients

Dallas, TX, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Spark Biomedical, Inc, a leader in wearable neurostimulation for opioid withdrawal relief, today announced the Company will join forces with Eric D....
January 29, 2018 17:14 ET | Source: ATI Physical Therapy

ATI Physical Therapy: Healthcare Experts Discuss Alternatives to the Opioid Crisis

Bolingbrook, Ill., Jan. 29, 2018 (GLOBE NEWSWIRE) -- Experts from cross-sections of the U.S. healthcare industry met on January 26th in Chicago at the ATI Forum: Opioid Edition, Presented by ATI...

Next Page keyboard_arrow_right